Figure 7
From: UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis
The EMT markers ZEB1 and vimentin in MDA231 cells after treatment with UTMD combined with NAC or miR-200c inhibitor analyzed by western blot analysis and statistically analyzed compared with the UTMD group. Data are represented as mean ± SD (n = 3) (*P < 0.05).
